A study by Schoppmann et al[33] showed that over-expression of HER2 would increase the probability of tumor metastasis and that inhibiting Her-2/neu may reduce tumor progression by blocking VEGF-C-mediated tumor cell proliferation and lymphogenic metastasis. This evidence concerns the gene VEGFC and neoplasm.